Last reviewed · How we verify

Very Low Nicotine Content Cigarettes

University of Minnesota · Phase 3 active Small molecule

Very Low Nicotine Content Cigarettes work by reducing the amount of nicotine in cigarettes, thereby decreasing the addictive potential and harm associated with smoking.

Very Low Nicotine Content Cigarettes work by reducing the amount of nicotine in cigarettes, thereby decreasing the addictive potential and harm associated with smoking. Used for Reducing nicotine intake in smokers.

At a glance

Generic nameVery Low Nicotine Content Cigarettes
Also known asReduced Nicotine Content Cigarettes
SponsorUniversity of Minnesota
ModalitySmall molecule
Therapeutic areaAddiction
PhasePhase 3

Mechanism of action

This is achieved through a reduction in the nicotine content of the cigarettes, which can help smokers reduce their nicotine intake and eventually quit smoking. The exact mechanism of action is not well understood, but it is believed to involve a combination of behavioral and physiological changes.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: